drugset / Trial / NCT00004700
Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: Evaluate the safety and efficacy of long term recombinant human insulin-like growth factor I in children with hyperinsulinism.
Timeline
- Start
- 1995-08
- Primary completion
- —
- Completion
- 1999-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mecasermin | Protein / enzyme biologic | — | Subcutaneous |